Stanley C. Erck, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 40,000 shares at $1.22 ($49K) on 2009-03-12, disclosed to the SEC on 2009-03-16.
Open-market purchase of $49k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |